Raymond James Financial Inc Scynexis Inc Call Options Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SCYX
# of Institutions
46Shares Held
12.2MCall Options Held
0Put Options Held
2K-
Federated Hermes, Inc. Pittsburgh, PA2.9MShares$2.32 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.79 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.33 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$983,1280.26% of portfolio
-
Amh Equity LTD627KShares$501,6290.97% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $26.1M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...